Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
195
-
Total 13F shares, excl. options
-
80.9M
-
Shares change
-
+337K
-
Total reported value, excl. options
-
$1.59B
-
Value change
-
+$5.51M
-
Put/Call ratio
-
1.55
-
Number of buys
-
82
-
Number of sells
-
-93
-
Price
-
$19.68
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q3 2021
229 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q3 2021.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 195 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.9M shares
of 106M outstanding shares and own 76.39% of the company stock.
Largest 10 shareholders include BlackRock Inc. (15.6M shares), VANGUARD GROUP INC (11.9M shares), RENAISSANCE TECHNOLOGIES LLC (8.25M shares), INGALLS & SNYDER LLC (7.05M shares), FEDERATED HERMES, INC. (3.86M shares), STATE STREET CORP (3.27M shares), DIMENSIONAL FUND ADVISORS LP (2.6M shares), GEODE CAPITAL MANAGEMENT, LLC (1.81M shares), Parallel Advisors, LLC (1.73M shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (1.49M shares).
This table shows the top 195 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.